Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

This study has been terminated.
(Administratively complete.)
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: May 13, 2002
Last updated: January 16, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)